Earnings
Biotech earnings reports provide critical updates on cash runway, pipeline progress, and commercial performance. For pre-revenue companies, cash burn rate and runway are the most closely watched metrics.
53 earnings tracked, next on Oct 21, 2026. Event dates and source records are shown with their available source context.
Earnings: Molina Healthcare Announces Second Quarter 2026 Earnings Release and Conference Call Dates
Molina Healthcare Inc (MOH)
Earnings: Philip Morris International to Host Webcast of 2026 Second-Quarter and First Six-Months Results
Philip Morris International Inc (PM)
Earnings: Quest Diagnostics to Release Second Quarter Financial Results on July 23, 2026
Quest Diagnostics Incorporated (DGX)
Earnings: Repligen to Report Second Quarter 2026 Financial Results
REPLIGEN CORP (RGEN)
Earnings: IQVIA to Announce Second-Quarter 2026 Results on July 28, 2026
IQVIA Holdings Inc. (IQV)
Earnings: Adaptive Biotechnologies to Report Second Quarter 2026 Financial Results on July 29, 2026
Adaptive Biotechnologies Corp (ADPT)
Earnings: Agios to Host Second Quarter 2026 Financial Results Conference Call and Webcast on July 30 at 8:00 a.m. ET
AGIOS PHARMACEUTICALS, INC. (AGIO)
Earnings: Alnylam to Webcast Conference Call Discussing Second Quarter 2026 Financial Results
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Earnings: Baxter to Host Second-Quarter 2026 Financial Results Conference Call for Investors
Baxter International Inc. (BAX)
Earnings: Madrigal Pharmaceuticals to Release Second-Quarter 2026 Financial Results and Host Webcast on July 30, 2026
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Earnings: Moderna to Report Second Quarter 2026 Financial Results on Friday, July 31, 2026
Moderna, Inc. (MRNA)
Earnings: Jazz Pharmaceuticals to Report Second Quarter Financial Results on August 3, 2026
Jazz Pharmaceuticals plc (JAZZ)
Earnings: Krystal Biotech to Report Second Quarter 2026 Financial Results on August 3, 2026
Krystal Biotech, Inc. (KRYS)
Earnings: AMGEN ANNOUNCES WEBCAST OF 2026 SECOND QUARTER FINANCIAL RESULTS
AMGEN INC (AMGN)
Earnings: Gilead Sciences to Release Second Quarter 2026 Financial Results on Tuesday, August 4, 2026
GILEAD SCIENCES, INC. (GILD)
Earnings: Geron Plans to Announce Second Quarter 2026 Financial Results on August 5, 2026
GERON CORP (GERN)
Earnings: Sarepta Therapeutics to Announce Second Quarter 2026 Financial Results
Sarepta Therapeutics, Inc. (SRPT)
Earnings: United Therapeutics Corporation to Report Second Quarter 2026 Financial Results Before Market Open on Wednesday, August 5, 2026
UNITED THERAPEUTICS Corp (UTHR)
Earnings: Elanco Confirms Date and Conference Call for Second Quarter 2026 Financial Results Announcement
Elanco Animal Health Inc (ELAN)
Earnings: Exelixis to Release Second Quarter 2026 Financial Results on Wednesday, August 5, 2026
EXELIXIS, INC. (EXEL)
Earnings: Viatris to Report Second-Quarter 2026 Financial Results on August 6, 2026
Viatris Inc (VTRS)
Earnings: Cryoport to Report Second Quarter 2026 Financial Results on August 6, 2026
Cryoport, Inc. (CYRX)
Earnings: Lantheus to Host Second Quarter 2026 Earnings Conference Call and Webcast on August 6, 2026, at 8:00 a.m. Eastern Time
Lantheus Holdings, Inc. (LNTH)
Earnings: Zymeworks to Report Second Quarter 2026 Financial Results on August 6, 2026
Zymeworks Inc. (ZYME)
Earnings: Immunovant to Report Financial Results for the First Quarter Ended June 30, 2026, and Provide Business Update on Thursday, August 6, 2026
Roivant Sciences Ltd. (ROIV)
Earnings: Iovance Biotherapeutics to Report Second Quarter 2026 Financial Results and Corporate Updates on Thursday, August 6, 2026
IOVANCE BIOTHERAPEUTICS, INC. (IOVA)
Earnings: Regulation FD Disclosure.: On July 16, 2026, Profound Medical Corp. (the "Company") issued a press release announcing that it plans to release its second quarter financial resul
Profound Medical Corp. (PROF)
Earnings: Ardelyx to Report Second Quarter 2026 Financial Results on August 6, 2026
ARDELYX, INC. (ARDX)
Earnings: BioMarin to Host Second Quarter 2026 Financial Results Conference Call and Webcast on Thursday, August 6, 2026, at 4:30pm ET
BIOMARIN PHARMACEUTICAL INC (BMRN)
Earnings: Immunovant to Report Financial Results for the First Quarter Ended June 30, 2026, and Provide Business Update on Thursday, August 6, 2026
Immunovant, Inc. (IMVT)
Earnings: Relmada Therapeutics to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026
RELMADA THERAPEUTICS, INC. (RLMD)
Earnings: LENZ Therapeutics to Report Second Quarter 2026 Financial Results and Recent Corporate Highlights on August 11, 2026
LENZ Therapeutics, Inc. (LENZ)
Earnings: Bicara Therapeutics to Report Second Quarter 2026 Financial Results and Business Updates on August 11, 2026, at 8:30 AM ET
Bicara Therapeutics Inc. (BCAX)
Earnings: Altimmune to Report Second Quarter 2026 Financial Results and Provide Business Update on August 12, 2026
Altimmune, Inc. (ALT)
Earnings: Omeros Corporation to Announce Second Quarter Financial Results on August 12, 2026
OMEROS CORP (OMER)
Earnings: Talphera to Report Second Quarter 2026 Financial Results on Wednesday, August 12, 2026
TALPHERA, INC. (TLPH)
Earnings: Valneva to Report First Half 2026 Consolidated Financial Results on August 13, 2026
Valneva SE (VALN)
Earnings: Outlook Therapeutics to Report Third Quarter Fiscal Year 2026 Financial Results and Host a Corporate Update Conference Call and Webcast on August 14, 2026
Outlook Therapeutics, Inc. (OTLK)
Earnings: Telix H1 2026 Results: Investor Webcast Notification
Telix Pharmaceuticals Limited (TLX)
Earnings: Phibro Animal Health Corporation to Host Webcast and Conference Call on Fourth Quarter and Fiscal Year 2026 Results
PHIBRO ANIMAL HEALTH CORP (PAHC)
Earnings: MindWalk Holdings Corp. to Report Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2027 on September 14, 2026
MindWalk Holdings Corp. (HYFT)
Earnings: Aytu BioPharma to Report Fiscal 2026 Full Year and Fourth Quarter Operational and Financial Results on September 22, 2026
AYTU BIOPHARMA, INC (AYTU)
Earnings: Earnings Scheduled For September 28, 2026
Inventiva S.A. (IVA)
Earnings: Addex Therapeutics to Report 2026 Half-Year Financial Results and Host Conference Call on September 28, 2026
Addex Therapeutics Ltd. (ADXN)
Earnings: Molina Healthcare Announces Third Quarter 2026 Earnings Release and Conference Call Dates
Molina Healthcare Inc (MOH)
Earnings: Quest Diagnostics to Release Third Quarter Financial Results on October 22, 2026
Quest Diagnostics Incorporated (DGX)
Earnings: IQVIA to Announce Third-Quarter 2026 Results on October 27, 2026
IQVIA Holdings Inc. (IQV)
Earnings: Beta Bionics to Announce Third Quarter 2026 Financial Results on October 27, 2026
Beta Bionics Inc. (BBNX)
Earnings: GE HealthCare to announce third quarter 2026 results on October 28, 2026
GE HealthCare Technologies Inc. (GEHC)
Earnings: AbbVie to Host Third-Quarter 2026 Earnings Conference Call
AbbVie Inc. (ABBV)
Earnings: Axsome Therapeutics to Report Third Quarter 2026 Financial Results on November 2
Axsome Therapeutics, Inc. (AXSM)
Earnings: Elanco Confirms Date and Conference Call for Third Quarter 2026 Financial Results Announcement
Elanco Animal Health Inc (ELAN)
Earnings: Regulation FD Disclosure.: August 10, 2026, Elite Pharmaceuticals, Inc. ("Elite" or the "Company") issued a press release announcing that
ELITE PHARMACEUTICALS INC /NV/ (ELTP)
Frequently asked questions
Why do biotech earnings matter for pre-revenue companies?
For clinical-stage biotechs, earnings reveal cash balance, quarterly burn rate, and runway — the metrics that determine whether a company can fund its pipeline to the next catalyst.
What pipeline information appears in biotech earnings?
Earnings calls often include trial enrollment progress, expected readout timing, and regulatory milestones alongside the financial results.
How are earnings dates tracked?
Earnings dates are aggregated from company announcements and market data sources, with source context shown where available.
Learn more
Biotech Earnings Reports: Key Metrics Beyond Revenue That Drive Stock Prices
Learn what to look for in biotech quarterly earnings reports, from cash burn and pipeline updates to guidance changes and hidden signals that move stock prices.
Biotech Cash Runway: Funding Before the Next Milestone
Build a dated cash-runway worksheet from filings. Separate usable cash, operating burn, financing and milestone assumptions before judging a biotech's funding gap.
Biotech Insider Trading Signals: What Form 4 Filings Reveal About Stock Direction
Learn how to interpret SEC Form 4 insider trading filings for biotech companies, identify meaningful insider buying patterns, and avoid common misinterpretations.
Key terms
From catalyst type to protocol condition
Decide when this event type should matter
Set the timing, confidence, company, drug, trial, and financing conditions that must hold before this catalyst changes a decision.